Exodus Point Capital Management, LP Exact Sciences Corp Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 65,701 shares of EXAS stock, worth $4.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
65,701Holding current value
$4.4 Million% of portfolio
0.03%Shares
20 transactions
Others Institutions Holding EXAS
# of Institutions
660Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.22 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$808 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$804 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$360 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...